eXoZymes, Inc.

EXOZNASDAQHealthcare● Active

$8.62

$-0.72(-7.71%)

Market Cap$73088911

P/E Ratio—

52W High$18.4

52W Low$7.08

Avg Volume5K

Open$9.00

Beta2.66

Earnings Financials Revenue

eXoZymes, Inc. (EXOZ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EXOZ · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 14, 2026

EPS Actual

-$0.28

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 14, 2026

After Market Close

EXOZ reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.09

Rev. $41.31B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.09

Rev. Est.$41.31B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 14, 2026	—	-$0.28	—	—	—	—
— Q1 FY2026	Mar 30, 2026	—	-$0.32	—	—	—	—
— Q4 FY2025	Nov 13, 2025	—	-$0.27	—	—	—	—
— Q3 FY2025	Aug 12, 2025	—	-$0.28	—	—	—	—
— Q2 FY2025	May 12, 2025	—	-$0.22	—	—	—	—

Q2 FY2026

May 14, 2026

EPS Actual

-$0.28

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 30, 2026

EPS Actual

-$0.32

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Nov 13, 2025

EPS Actual

-$0.27

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 12, 2025

EPS Actual

-$0.28

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 12, 2025

EPS Actual

-$0.22

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for EXOZ.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 14, 2026	—	$9.88	$10.02	+1.42%
— Q1 FY2026	Mar 30, 2026	—	$7.15	$7.30	+2.10%
— Q4 FY2025	Nov 13, 2025	—	$16.50	$16.40	-0.61%
— Q3 FY2025	Aug 12, 2025	—	$9.86	$10.03	+1.72%
— Q2 FY2025	May 12, 2025	—	$13.01	$12.54	-3.61%

Q2 FY2026+1.42%

Report Date

May 14, 2026

EPS Beat/Miss

—

Price Before

$9.88

Price After

$10.02

Q1 FY2026+2.10%

Report Date

Mar 30, 2026

EPS Beat/Miss

—

Price Before

$7.15

Price After

$7.30

Q4 FY2025-0.61%

Report Date

Nov 13, 2025

EPS Beat/Miss

—

Price Before

$16.50

Price After

$16.40

Q3 FY2025+1.72%

Report Date

Aug 12, 2025

EPS Beat/Miss

—

Price Before

$9.86

Price After

$10.03

Q2 FY2025-3.61%

Report Date

May 12, 2025

EPS Beat/Miss

—

Price Before

$13.01

Price After

$12.54

Beat Rate0 / 5 quarters

Largest Move-3.61% (Q2 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

eXoZymes, Inc. (EXOZ) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.28 (in line with the analyst consensus of —). The next EXOZ earnings date is expected around September 1, 2026.

Each quarter, investors track EXOZ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EXOZ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

EXOZ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

EXOZ earnings · 4 questions

eXoZymes, Inc.'s next earnings report is expected around September 1, 2026. EXOZ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EXOZ historically reports after market close (AMC).

EXOZ earnings datewhen is EXOZ earningsEXOZ next earnings datewhen does EXOZ report earningsEXOZ earnings calendar

▸ Source: FMP · eXoZymes, Inc. SEC filings · US GAAP · eXoZymes, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026